Oklo (OKLO) Stock Climbs Despite $33M Q1 Loss: NRC Milestone Drives Optimism

TLDR

• Oklo reported a Q1 net loss of $33.1 million ($0.19 per share), significantly higher than last year’s $9.8 million loss, generating no revenue.
• The company received Nuclear Regulatory Commission approval for Aurora powerhouse Principal Design Criteria last week.
• CEO Jacob DeWitte reaffirmed plans to launch commercial operations no later than 2028.
• The company held $1.59 billion in cash plus $614.5 million in marketable debt securities at quarter-end, accounting for roughly 82% of total assets.
• Following Q1 earnings, H.C. Wainwright maintained its Buy rating with a $90 price target.

Oklo stock edged 0.6% higher during Wednesday’s premarket session following the nuclear technology firm’s first-quarter earnings release and announcement of a significant regulatory breakthrough — despite mounting losses.

Oklo Inc., OKLO

The nuclear startup disclosed a Q1 net loss of $33.1 million, equivalent to $0.19 per share. This represents a substantial increase compared to the year-ago loss of $9.8 million, or $0.07 per share. Wall Street analysts had projected a $0.20 per share loss, meaning the company narrowly beat consensus estimates.

Oklo remains revenue-free. As a pre-commercial company, it doesn’t yet generate income, making conventional valuation methods challenging to apply.

Capital expenditures totaled $32.8 million during the quarter on infrastructure and equipment investments — exceeding the $29.8 million analyst consensus. Operating expenses reached $51.5 million, reflecting a roughly 10% decline from the prior quarter’s $57.1 million.

The company closed the first quarter holding $1.59 billion in cash alongside $614.5 million in marketable debt securities. Combined, these liquid assets comprise approximately 82% of Oklo’s total asset base.

Shares had declined 5.8% in the prior session before Wednesday’s premarket recovery.

NRC Greenlights Critical Aurora Design Framework

The major regulatory development: the Nuclear Regulatory Commission granted approval for the Principal Design Criteria governing Oklo’s Aurora powerhouse facility at Idaho National Laboratory last week.

This approval establishes the fundamental safety and operational standards for the facility. While representing significant progress in the licensing journey, full commercial authorization remains outstanding.

CEO Jacob DeWitte has repeatedly stated in interviews with Barron’s that the company expects to commence commercial operations by 2028 at the latest.

Alternative Revenue Streams Begin Emerging

As Aurora progresses through regulatory channels, Oklo is developing additional revenue generation avenues.

The company’s Atomic Alchemy subsidiary obtained licensing approval earlier this year to commence sales from its Idaho-based radiochemistry facility. During Tuesday’s announcement, Oklo revealed its first isotope customer was “pending.”

The nuclear startup has also bolstered its credibility through strategic collaborations. In recent weeks, Oklo partnered with Nvidia’s AI infrastructure division to enhance nuclear fuel modeling and simulation capabilities alongside Los Alamos National Laboratory.

Meta Platforms counts among Oklo’s current customer roster, lending additional legitimacy and investor appeal to the company.

Following its May 2024 public debut, Oklo has traded primarily on future potential. The stock skyrocketed 238% throughout 2025 while the S&P 500 advanced 16%. Performance has moderated in 2026 — shares are up just 2.6% year-to-date compared to the S&P 500’s 8.1% climb.

Despite producing zero revenue, the company commands a $12.81 billion market capitalization — a valuation multiple some analysts have characterized as potentially excessive.

H.C. Wainwright reaffirmed its Buy rating and maintained its $90 price target on Oklo shares following the first-quarter report.

The post Oklo (OKLO) Stock Climbs Despite $33M Q1 Loss: NRC Milestone Drives Optimism appeared first on Blockonomi.